comparemela.com

Type 1 Diabetes Ins News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CNN At This Hour With Kate Bolduan July 7, 2024

midterms. plus charges against a major company and a guilty plea for financing isis. and actor kevin spacey is back on the stand today defending himself against sexual assault allegations. this is what we re watching at this hour. thank you for being here. i m kate bolduan. president biden is making a move today to try and put abortion rights back in the spotlight and back on the ballot. with the midterm elections three weeks from today. the president is speaking soon at a dnc event in washington where he is expected to make a promise that his first move in the new year will be to codify roe v. wade, that is if democrats don t lose power. this is one of the many topics that candidates debated last night in key races across country. but let s get to the white house. jeremy diamond is standing by. what is the president laying out in this speech. reporter: well president biden is trying to put an issue that he and his advisers believe is advantageous to democrats front a

CNN At This Hour With Kate Bolduan June 4, 2024 15:54:00

americans with diabetes have rationed their insulin in the past year. the analysis shows the cost of the drug is pushing people to skip or reduce their doses or pushed off buying it altogether. dr. tara narula joins us with more. this isn t a great picture being painted. this was a researcher that looked at 982 diabetics who used insulin and estimated 1.3 million americans or 16.5% of those diabetic rationed their insulin use last year, most commonly seen in type 1 diabetes ins under 65, middle income and african americans. more common in the uninsured population but also seen in those with private insurance. we know that insulin prices have soared over the last 10, 15 years and many people have to pay hundreds to thousands some don t have an option. it s not if you want to. we call it oxygen for type 1

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.